It was great to be able to share our perspective with leaders in MA. Across four days, this meeting will unite 500+ leading experts in Boston from innovative biotechs, large pharma, academia, and key service provider companies, delivering actionable insights and valuable networking opportunities to accelerate gene therapy progress. Canada (+1)
Powered by World Pharma Today - Designed by Leo MarCom. Integrate the Patient Voice to Develop Safer & More Effective Gene Therapies That Are Meaningful to Patients, Join us to hear directly from companies and institutions including. Algeria (+213)
Hong Kong (+852)
All in-person participants are required
Finland (+358)
Sierra Leone (+232)
South Africa (+27)
Kazakhstan (+7)
Mongolia (+976)
Peru (+51)
Myanmar (+95)
Vanuatu (+678) Netherlands (+31) Cuba (+53) Bahrain (+973) Event Organizer: Kisaco Research Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene. Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Cape Verde Islands (+238) This is why you must attend the 7th Cell & Gene Therapy Summit 2022where global expert speakers will discuss the most important topics on emerging advances in the field of cell and gene therapy, the regenerative potential of stem cells, application of T- cells and Cart-T in the field of immuno-oncology, novel gene-editing tools and delivery methods, vector development, regulatory approaches, commercialisation strategies, ethical considerations and more in order to help you improve efficiencies across all phases of Cell & Gene Therapy development & production. Bangladesh (+880) The past five years have been a critical turning point for gene therapy. Eritrea (+291) By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information. The objectives of the PIC Scheme are the same as those of Equip Global. Whether it is learning how to educate and upskill cross-functional teams or tailoring engagement strategies with external HCPs, regulators and patient advocates, join us to determine how best to create a cohesive and streamlined launch strategy specifically for gene therapy products. Cancellations received from January 22, 2023: no refund will be made. Norway (+47) London, Cyprus North (+90392) Visit the Download Centre to access related reports, articles, interviews and other useful resources. Crecia Magee, President & Principal Talent Executive. File your receipt (which we will email you), record of attendance (which we will provide you at the event) and the completed PIC form with your accounts department which they will submit to IRAS to process the claim.
Tunisia (+216) Tonga (+676) For further information around Health and Safety onsite, please visit our FAQs page. * Please note, this is subject to change at any time without prior notice. E:info@hansonwade.com. Seychelles (+248) ", Lots of useful information and good variety of perspectives., Exciting new way of participating in scientific conference and discussion., Incredibly positive and eye-opening experience for a scientist new to the field., Associate Director, Global Patient Advocacy & Engagement, Deputy Director, Officer of Rare Diseases Research, T: +44 (0)20 3141 8700
Armenia (+374) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Azerbaijan (+994) Uruguay (+598) Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. We will provide you with full supporting documentation after the event and assist you in getting the claim completed. Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Continuous training and upgrading of your employees is key to the success of your organization. We use cookies to ensure that we give you the best experience on our website. Cyprus South (+357) Sri Lanka (+94) Indonesia (+62) Looking to the future, biopharmaceutical , biotech companies, and other stakeholders, including regulators and researchers will need to collaborate to develop a new pipeline of research from biological concept to medical practice. We will delve into the unique challenge encountered when working with gene therapies, from adapting to the clinical realities of the rare disease space to handling long-term follow up and post-launch regulatory scrutiny, equipping you with the insights required to for a successful and patient-centric launch. Guinea (+224) Boston, The conference was very well attended and very informative to a wider industry audience; not just manufacturing, but clinical and commercialization as well., Outstanding networking. This event thus hopes to gather the knowledge and expertise of scientists in vector For further information around Health and Safety onsite, please visit our FAQs page here or for more information on the B Together Policy, please see here. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Whether you're working with AAV or lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative new tools to support safe and effective gene therapy development. One Avenue de Lafayette, Boston, Massachusetts, United States, 02111. Hungary (+36)
Sweden (+46) Access the 2022 full event guide to see what you missed. Israel (+972) This event is tailor-made for Heads, Program Leads, Senior Managers & Executives from across pharmaceutical, biopharmaceutical and biotechnology companies involved in cell & gene therapy developments including the following departments: What are you waiting for? The 2023 Advancing Gene Therapy conference will be held in Hyatt Regency Boston, MA. Pre-filled Syringes and Injectable Drug Devices - Challenges in Cell & gene therapy, 2nd Multi-Functional Cell Therapies Summit, 2nd TGF- for Immuno-Oncology Drug Development Summit, 5th Antigen-Specific Immune Tolerance Summit - Cell and gene therapy approaches, Formulation & Delivery US: Gene and Cell Therapies, Genetic Vaccine Analytical Development Summit, 5th Annual Gene Therapy for Rare Disorders, 11th Spring Meeting ISBioTech - Viral vectors and vaccines, 10th Neurodegenerative Drug Development Summit, 3rd Gene Therapy for Blood Disorders Summit, 2nd Gene Therapy for Muscular Disorders Summit, Global Bioprocessing Summits - Cell & Gene therapy analytics and manufacturing, ABC-RI International Forum: Spring Edition 2022 - Gene and Cell Therapies for Healthy Ageing, European Society of Gene and Cell Therapy (ESGCT) Spring School, 4th Neuroimmunology Drug Development Summit, SMis 9th Annual Conference Pre-Filled Syringes East Coast - Viral vector deliveries, 3rd Supply Chain and Logistics for Cell Therapies Summit, 5th Neoantigen Summit Europe - T-cell therapies, PEGS Boston Summit - Gene Therapy R&D Analytics, SMis 4th Annual Conference Injectable Drug Delivery - Gene Therapies, Global Bioprocessing Summit Europe - Cell & Gene therapy analytics and manufacturing, American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting, Advanced Therapies (ATMP) Challenges for Routine Applications, PrecisionMed Exhibition and Summit 2022 - Gene Medicines, 2nd Genetic Vaccine Development for Infectious Diseases Summit, ALS Drug Development Summit - Gene & Cell Therapies, 3rd Annual Gene Therapy Analytical Development Europe Summit 2022, 2nd Annual Gene Therapy Patient Engagement Summit, 9th Monolith Summer Symposium Monoliths, Gene Therapy, Vaccines, Next Generation CAR & T Cell Therapies 2022, 2nd Tumor Myeloid-Directed Therapies Summit - Gene and Cell Therapies, 2nd Inner Ear Disorders Therapeutics Summit - Gene Therapies, 1st Rare & Genetic Neurodegenerative Drug Development Summit - Gene Therapies, 3rd TCR-based Therapies for Solid Tumors Summit, 3rd Annual Gene Therapy for Neurological Disorders Europe, BCMA Targeted Therapies - CAR-modified T-cell therapy, 2nd Annual Next Generation Gene Therapy Vectors Summit, 2nd Annual mRNA-Based Therapeutics Summit, iPSC Manufacturing Summit - Gene and Cell therapies, Bioprocessing Summit - Gene and Cell therapies, The Cell Therapy Durability Response Summit, Vector Development for Cell and Gene Therapy Summit, 3rd Annual Gene Therapy for Ophthalmic Disorders, Reuters Events: Cell & Gene Therapy USA 2022, mRNA Process Development & Manufacturing Summit, Oligonucleotide Therapeutics and Delivery 2022, International Human Gene Therapy Conference, Cell & Gene Therapy Manufacturing & Commercialization US, XXIX Congress of the European Society of Gene and Cell Therapy (ESGCT), Global Bioprocessing Summit and Expo - ATMP Development, 3rd Annual Gene Therapy Immunogenicity Summit, Process Development for Cell Therapies Summit, Reuters Events: Oncology at Total Health 2022, 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022, 8th Annual Cell & Gene Therapy Manufacturing Congress, Emerging Non-Coding RNA Therapeutics Summit, Joint meeting of The Australasian Society for Stem Cell Research (ASSCR) and the Australasian Gene and Cell Therapy Society (AGCTS), 4th Annual Gene Therapy Analytical Development, Cell & Gene Therapy Manufacturing & Commercialization Europe, Your conference not listed? Nauru (+674) Guinea - Bissau (+245) Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Join us to hear directly from companies and institutions including Spark Therapeutics, Ultragenyx, FDA, Global Genes, and CRISPR Therapeutics on key topics including managing expectations across gene therapy development, navigating patient input on one-time transformative treatments with novel clinical trial designs combined with extensive follow-ups, and developing educational materials on gene therapy to raise awareness in collaboration with patient advocacy organizations. San Marino (+378) For sponsorship and exhibition opportunities, please contact: Biogate Scientific Center brings to you the 3rd edition Vaccines Summit Boston 2023 scheduled for May 22-24, 2023. Vietnam (+84) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Northern Marianas (+670) Iraq (+964) CHI has instituted mandatory health and safety protocols for all in-person participants. Talks include enhancing the knowledge transfer between departments, bridging between analytical methods with regards to QC/PD, and enhancing in-process development support. Potency Assay Development and Validation for Gene Therapy Products, Lyndi Rice, PhDHead, QC Viral Vectors, Biomarin, AAV Capsid Engineering to Increase Human Tissue Tropism and Transduction. Outstanding networking. Have a negative COVID-19 test result from an FDA-authorized over-the-counter antigen test within 24 hours prior to arriving at the event. NW3 3ST. Kiribati (+686) Present your research and cases to your colleagues and peers to get feedback, new ideas, and recognition, and make a name for yourself in the field. The latest discoveries and most up-to-date research will be revealed and discussed at AGT-2023. Jamaica (+1876) Dominica (+1809) Ltd., All Rights Reserved. Attendees of the Gene Burundi (+257)
The 2nd Gene Therapy Medical Affairs Summit is dedicated to exploring the pivotal internal and external role Medical Affairs plays in delivering gene therapies to patients. Focused specifically on enhancing your gene therapy comparability approach, this event will ensure you can maintain safety, quality, consistency and efficacy while adapting manufacturing processes, methods and platforms, to satisfy regulatory demands and avoid costly delays to clinical programs. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Copyright 2019 Leo MarCom Pvt. Syria (+963) Bosnia Herzegovina (+387) Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Senegal (+221) Panama (+507) The massive success of cell and gene therapies in recent years has made the need for effective, large scale vector engineering greater than ever. Manager, Business DevelopmentT:781.972.5452jgerardi@healthtech.com, Bethany GrayDirector of Product MarketingT: 781.972.5494bgray@healthtech.com, 250 First Avenue, Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425 Latvia (+371) Head Business Development and Partnership, Vice President, Process Development Viral Vector Technologies. If you continue to use this site we will assume that you are happy with it. In the context of scaling up gene therapy development to achieve commercial goals and mounting regulatory scrutiny, the 2nd Annual Gene Therapy Comparability Summit will unite large pharma and innovative biotechs to ensure you can establish comparability at every stage of development, supporting a seamless transition to the larger scales required for commercialization. Pimlico, London CTRL + SPACE for auto-complete. Russia (+7) USA (+1) This years agenda includes a novel track designed for quality control and process development groups working in gene therapy. Madagascar (+261) Congo (+242) Event Venue: Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115, United States Whether you're working with AAV, non-viral vectors or lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative new tools to support safe and effective gene therapy development. Honduras (+504) Whilst Gene Therapies are set to transform treatment paradigms, their complex nature and high price tag presents unique challenges. Malawi (+265) Across three carefully curated days, this streamlined one-track summit will unite key gene therapy leaders from large pharma to ground-breaking biotech, academics to exciting service providers, all with the purpose of paving a way forward to successfully launch gene therapy products in Europe. Enriching and inspiring experience, an highly effective and interactive digital event with thought leaders sharing insights, experiences and vision on the key strategic role of Medical Affairs in delivering gene therapy to patients. Uncover the Robust Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products. Gene Therapy for Rare Disorders is dedicated to overcoming the unique drug development challenges encountered in transforming gene therapy concepts into reality for rare disease patients in need. French Polynesia (+689)
Lesotho (+266) Reserve your seat today and take advantage of the early bird discounted prices! Turkmenistan (+7) SW1V 1EQ. Turkmenistan (+993) Mozambique (+258) Korea South (+82) Falkland Islands (+500) Cook Islands (+682) Cancellations received up and including September 18, 2022: full refund less a $80 towards the administrative fee. With our extensive marketing experience and strategy, your partnership with Advancing Gene Therapy will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. Dont miss your chance to be involved in the 7th Cell & Gene Therapy Summit 2022, Live Online, and be updated with the latest market information you will need to stay on top of the game! Andorra (+376) Thailand (+66) The Gene Therapy Comparability Summit returns for the second year providing you with all the practical insights to optimize your gene therapy comparability approach.
Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Malta (+356) Slovenia (+386) Malaysia (+60) Macedonia (+389) Tuvalu (+688) You will be asked your results at registration. For more information, please email us at enquiry@equip-global.com! High quality speakers, outstanding job., T: (+1) 617 455 4188 Ireland (+353) Haiti (+509)
Hanson Wade's goal is to accelerate progress within organisations and across industries. Join 150+ analytical pioneers to discover the realities of working with tools like dPCR, AUC and HPLC, as well as how and where these tools can be most effective in process development, and what the European regulators expect in order to grant approval.
Leverage their knowledge and experiences to ultimately ensure effective creation and implementation of patient-centric gene therapy programs. Bringing together key industry leaders and covering a range of topics including capsid optimisation using AAV vectors, process optimisation using lentiviral and adenoviral vectors, innovative non-viral delivery options and the importance of vector serotype for improved durability, its a key opportunity to gain the actionable insights youll need to optimise your manufacturing process and improve tissue-specific targeting and safety profiles for your pipeline. Why digitization is a must for competitive manufacturing. By giving voice to pioneering drug developers with success stories to share, experts in regulatory affairs, and the regulators themselves, this meeting is your comprehensive guide to unpicking the thorniest regulatory challenges.
Vatican City (+379) Belarus (+375) Zimbabwe (+263). Trinidad & Tobago (+1868) St. Lucia (+1758) E:info@hansonwade.com. 425 Summer Street, Great experience where I learned a lot from experts who were sharing their drive and best practices in the gene therapy MA environment.. Grenada (+1473) Philippines (+63) Hanson Wade's goal is to accelerate progress within organisations and across industries. How to eliminate shop floor errors that cost manufacturers millions. Iran (+98) By continuing to use this site you consent to the use of cookies, unless disabled from your browser. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Cayman Islands (+1345) Mexico (+52) El Salvador (+503) Macao (+853) Botswana (+267) Take the opportunity to meet industry leaders and subject experts; and enhance your network globally through the networking events. Switzerland (+41)
Vice President, Global Regulatory Affairs, Patient Expert & Member of the Committee for Orphan Medicinal Products, Acting Director, Office of Rare Diseases Research, NCATS, Chair of Committee for Orphan Medicinal Products, T: +44 (0)20 3141 8700 This policy requires individuals to show you proof of vaccination against COVID-19 in order to gain admittance to the conference venue. Costa Rica (+506) As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, View the 2022 event guide to see what you missed. Equatorial Guinea (+240) Far from the typical meet-and-greet exhibition experience, you as a sponsor or exhibitor will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list. Iceland (+354) We use cookies to give you the best experience. Greece (+30) Guam (+671) #VSBOSTON provides an iconic platform where science, and business converge. Moldova (+373) Event Website: https://hubs.ly/Q01c-M4h0
E:info@hansonwade.com. As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, Gene Therapy for Rare Disorders provides in-depth insights from experts who know how to drive clinical progress, optimize manufacturing, and demonstrate the value of gene therapy products to regulators, payers, and patients. Denmark (+45) VP Medical and Patient Affairs, Encoded Therapeutics, Inc. SVP of Global Commercial Development & TA Strategy, CSL Behring. It was great to be able to share our perspective with leaders in MA. Lebanon (+961) Singapore (+65) Estonia (+372) Copyright EquipGlobal 2017 All Rights Reserved, Vice President and Head, Process Development & MSAT, Global Regulatory Affairs Associate Project Lead, Associate Vice President Associate Vice President, Head, Cell Therapies and Analytical, http://www.iras.gov.sg/irasHome/uploadedFiles/Quick_Links/Tax_forms/Business_and_employers/Cash%20Payout%20Application%20Form_B2011_final.xls, http://www.iras.gov.sg/irashome/picredit.aspx, Learn and benchmark yourself with leading cell & gene therapy experts so that, Select, register and pay for your conference/training course of your choice. Guadeloupe (+590) Solomon Islands (+677) We are very happy to be able to offer you a discounted accommodation in the Hyatt Regency Boston Woburn from April 17 - 19, 2023. Turks & Caicos Islands (+1649)
Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Gibraltar (+350) Join Orchard Therapeutics, PTC Therapeutics, Sanofi Genzyme and others as we start to define both the role and value of Medical Affairs from early development of gene therapies right the way to a launch environment. How a digital system can decrease post-production time by 80%. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Australia (+61) Cancellations received between September 19 until January 21, 2023: 50% will be refunded. Reunion (+262) Are You Prepared for the New Digital Reality? Please send your room requests to sachin.sravan@bsc.events with the subject line "Accommodation During AGT-2023". Faroe Islands (+298) Vector Development for Cell and Gene Therapy Summit 2022. Germany (+49) The Gene Therapy Analytical Development 2021 conference contained a wealth of content from many industry insiders and had information indispensable to the analytical drug development process. NanoSomiX Inc, Senior Director, Head of Analytical Development, Associate Director, Analytical Development, Associate Director, NGS Leader, Genomics Medicine Unit CMC, Senior Director, Analytical Sciences & Technology, 10% Discount 3 Passes Be a part of the platform to hear first about the latest news in gene therapy and update your knowledge. E:info@hansonwade.com. Guyana (+592)
Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Uzbekistan (+7) Saudi Arabia (+966) Bahamas (+1242)
Bolivia (+591) Though R&D efforts focussed on reducing immunogenicity and toxicity whilst improving redosing ability and durability are showing promise, companies are still striving to optimise these technologies and develop next-generation targeted, persistent and tolerable cell and gene therapies. Bhutan (+975) Welcome to the 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022, Gain European Regulatory Clarity to Progress Efficient & Robust Gene Therapies for Rare Disease. Anguilla (+1264) The Vector Development for Cell and Gene Therapy Summit is North Americas only event focused exclusively on addressing challenges in vector improvement for both ex vivo and in vivo approaches. Taiwan (+886) Cameroon (+237) strategies, these gene therapeutics are not only life-changing for patients with rare diseases, but are also laying the foundation for potential treatments of other unmet medical needs. Brazil (+55) In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products. Nicaragua (+505) In this context, the 2nd Annual Gene Therapy Patient Engagement Summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers, patient groups and patients themselves to address the specific challenges of genetic therapy patient engagement, generating actionable insights through detailed case studies and open, honest discussions. Nigeria (+234) Micronesia (+691) Gabon (+241) Comoros (+269) Write CSS OR LESS and hit save.
Crecia Magee, President & Principal Talent Executive, PharmaFinders, T: +1 617 455 4188 Colombia (+57) Togo (+228) Your attendance at any Equip Global conference or training course is eligible for PIC credits, either as a 40% cash refund or 400% tax deduction. Romania (+40) Egypt (+20) Global Vice President, Technology Development, LogicBio Therapeutics Inc. Hanson Wade's goal is to accelerate progress within organisations and across industries.
Ukraine (+380) Founder & CSO, GenomeFrontier Therapeutics, Inc. Chief, Division of Cellular and Molecular Therapy, University of Florida College of Medicine, FL, USA, Hamilton, Brook, Smith & Reynolds, MA, USA, Vice President Business Development and Alliances, Global Head Gene Therapy Technical Development, Department Chairman, Department of Urology, UT MD Anderson Cancer Center,TX, USA, Director, Cell and Gene Therapy, Latham Biopharm Group, Senior Director of Technology, Gene Therapy, Repligen Corporation, and avail upto 30% discount on registration. India (+91) E:info@hansonwade.com, Victoria Park Plaza Hotel The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. Yemen (South)(+967) Djibouti (+253) Liberia (+231) Sr. Director Analytical Assay development, T: +1 617 455 4188 There are however several challenges which needs to be overcome and debated including manufacturing processes, scalability, regulatory compliance, pharmacovigilance & risk management, post-marketing activities, commercialization & market access, and patient evaluation & side-effect management amongst others. Registration is free and allows users complete access to all sections of the site, including archived news items. Thank you.
Niue (+683) Monaco (+377) Central African Republic (+236) Kenya (+254) Eleonora Russo, Director Rare Disease Medical, Pfizer, We really enjoyed the partnership opportunity and look forward to see what lasting relationships might develop from the conference. France (+33) Across four days of curated content, incorporating detailed case studies from leading CMC, Regulatory, Analytical and Process Development experts, this is your opportunity to gain a hands-on, practical insight into exactly what it takes to execute successful comparability studies. Poland (+48) Bermuda (+1441) If you work in quality control, quality assurance, or process development - weve listened and weve answered. Select Country French Guiana (+594) Bulgaria (+359) The health, safety and well-being of our community remains our highest priority, therefore, all attendees will be required to complete a health declaration prior to attending the event, as well as comply with the City of Bostons B Together policy. For more information visit http://www.iras.gov.sg/irashome/picredit.aspx. Lithuania (+370) 239 Vauxhall Bridge Rd,
This is your comprehensive guide to define your commercial path forward. Brunei (+673) Morocco (+212) Ghana (+233) We value your ROI and will work with you directly on your specific goals and targets thats why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated. Contact No: +44 (0)20 3696 2920 As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever. Angola (+244) Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. If you are unable to attend the summit at any given time, we will transfer your ticket to next year. Martinique (+596)
MA, 02210.
Click here to suggest. From the first approved oligonucleotide-based therapy to the success of CAR-T cell therapies, followed by the recent in-vivo gene therapies and the emerging gene editing You will be asked to present your vaccination card (or a photo of it) at registration. As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important. Our platforms are neutral, so that our attendees get the right information from the most relevant people. Significant investment is going into this sector. Whether you're looking for specific characterisation, potency or infectivity approaches to improve your current analytical toolbox or if you're seeking to understand how gene therapy analytics differ from other biologics you've worked on in the past, this focused, technical event will provide insights specifically on the unique analytical challenges posed by gene therapy vectors, delivered by 'boots on the ground' scientists grappling with these challenges first-hand. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.